 Dario Continues to Expand its Employer Contracts Across Broad Range of Solutions NEW YORK, Sept. 9, 2021 PRNewswire -- DarioHealth Corp. Nasdaq: DRIO, a leader in the global digital therapeutics DTx market, announced today that it has entered into an agreement to provide its suite of digital therapeutics for diabetes, hypertension and pre-diabetes to a Northeast regional employer Employer. 